Outlook Therapeutics (OTLK) Total Debt Growth (1y) (2016 - 2026)
Outlook Therapeutics (OTLK) Total Debt Growth (1y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
5.94% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Outlook Therapeutics |
51.56 Mn |
43.81 Mn |
-21,888.00 |
-18.63% |
| Date | Value |
|---|
| Mar 31, 2026 |
-18.63% |
| Dec 31, 2022 |
231.31% |
| Dec 31, 2021 |
-9.88% |
| Sep 30, 2021 |
1,103.92% |
| Mar 31, 2021 |
402.43% |
| Dec 31, 2020 |
27,938.89% |
| Sep 30, 2020 |
-86.60% |
| Jun 30, 2020 |
-91.94% |
| Mar 31, 2020 |
-99.67% |
| Dec 31, 2019 |
-73.51% |
| Sep 30, 2019 |
3,991.29% |
| Jun 30, 2019 |
3,310.33% |
| Mar 31, 2019 |
3,234.50% |
| Dec 31, 2018 |
-98.84% |
| Sep 30, 2018 |
-98.76% |
| Jun 30, 2018 |
-8.10% |
| Mar 31, 2018 |
-96.60% |
| Dec 31, 2017 |
140.69% |
| Sep 30, 2017 |
371.03% |
| Jun 30, 2017 |
-71.33% |
